In one study using leukemia cell lines, high level of G6PD was found in DOX-resistant cells 39, while in another study using low-metastatic human breast cancer, MCF-7 cell line, the level of G6PD was significantly decreased in DOX-resistant MCF-7 cells 40-42. Here, G6PD is linked to breast carcinoma.